Regulatory Harmonization Needs for Farm-to-Fork Bacteriophage Applications in South American Food Systems. [PDF]
Parra B +16 more
europepmc +1 more source
Cefdinir reprograms Gram‐positive bacteria to synergize with lysozyme against superbugs
Abstract Multidrug‐resistant (MDR) bacteria pose a critical global health threat, urgently requiring solutions. Cefdinir, the highest‐selling third‐generation cephalosporin but one now facing clinical obsolescence due to escalating resistance, is conventionally classified as a nascent cell wall synthesis inhibitor.
Qi Zhang +6 more
wiley +1 more source
ICP1 bacteriophage treatment antagonizes colonization of the zebrafish larval intestine by <i>Vibrio cholerae</i>. [PDF]
Sidi Mabrouk A +9 more
europepmc +1 more source
Bacteriophage therapy for multidrug-resistant pediatric infections: a re-emerging precision antimicrobial strategy. [PDF]
Amjad A, Shahzad A, Segawa F.
europepmc +1 more source
Bacteriophage Lysin CF-301, a Potent Antistaphylococcal Biofilm Agent [PDF]
Raymond Schuch +4 more
openalex +1 more source
Propagation, DNA Extraction Optimization and Genome Sequencing of Bacteriophage
This study conducted bacteriophage propagation of three different strains for eight generations on a stable Stenotrophomonas maltophilia host. Infectivity of the bacteriophage was evaluated. Subsequent upscaling, filtration and DNA extraction was carried
Aronee, Atica Amin
core
Rapid and quantitative phage susceptibility test by ramanome
Abstract Antimicrobial resistance poses an escalating global threat, renewing interest in bacteriophage therapy as a precision alternative to antibiotics. However, clinical translation remains hindered by the lack of rapid and quantitative phage susceptibility testing (PST) platforms capable of evaluating host range, infection potency, and effective ...
Xiao Han +10 more
wiley +1 more source
Evaluation of the Potential Efficacy of Bacteriophage Therapy for the Management of Pressure Ulcers and Its Comparison to Conventional Therapy: A Randomized Controlled Trial. [PDF]
Meena K +4 more
europepmc +1 more source

